Lee, M. W., Sriprasert, I., Phung, P. G., Pino, C., Woll, S. M., Vallejo, A., Furey, K. B., Muderspach, L. I., Roman, L. D., Wright, J. D., & Matsuo, K. (2025). Trends and comparisons of palliative care utilization for patients with metastatic gynecologic malignancy. International Journal of Gynecological Cancer, 101631. https://doi.org/10.1016/j.ijgc.2025.101631

Matsuo, K., Lee, M. W., Furey, K. B., Yang, J. L., Roman, L. D., Klar, M., Sood, A. K., & Wright, J. D. (2025). Estimating high-grade serous fallopian tubal carcinoma in the era of tubal hypothesis. International Journal of Gynecological Cancer, 101657. https://doi.org/10.1016/j.ijgc.2025.101657

Woll, S. M., Lee, M. W., Neuman, M. K., Pino, C., Klar, M., Roman, L. D., Wright, J. D., & Matsuo, K. (2024). Stage IC grade 1 endometrioid adenocarcinoma of the ovary: assessment of post-operative chemotherapy de-escalation. International Journal of Gynecologic Cancer, ijgc-2024-005718. https://doi.org/10.1136/ijgc-2024-005718

Diggs, A., Huang, Y., Melamed, A., Szamreta, E., Monberg, M. J., Hershman, D., & Wright, J. D. (2024). Patterns of use of primary and first-line chemotherapy for recurrence among patients with cervical cancer. International Journal of Gynecologic Cancer, 34(7), 1001–1010. https://doi.org/10.1136/ijgc-2023-004860

Liu, J., O’Malley, D., Nieuwenhuysen, E. V., Moore, K., Hamilton, E., Yeku, O., Bouberhan, S., Hou, J., Schröder, D., Wang, B., Yoo, S.-Y., Govindraj, S., Brouwer-Visser, J., Peterman, M., Schmidt, T., Barnes, B., Lowy, I., Uldrick, T., Miller, E., & O’Cearbhaill, R. (2023). PO011LBA/#1512  Ubamatamab (MUC16XCD3 bispecific antibody) with or without cemiplimab (Anti-PD-1 antibody) in recurrent ovarian cancer: phase 1 clinical and biomarker results. Plenary 03: Oral Abstract Presentations – Ovarian Cancer. https://doi.org/10.1136/ijgc-2023-igcs.11

Dioun, S., Chen, L., Gockley, A., Melamed, A., Clair, C. S., Hou, J., Khoury-Collado, F., Elkin, E., Hershman, D., & Wright, J. (2022). 31/#204 Cost-effectiveness of hysterectomy at the time of risk-reducing bilateral salpingooophorectomy for patients with BRCA1 mutations. Featured Printed Posters (Poster Rounds with the Professors). https://doi.org/10.1136/ijgc-2022-igcs.75

Diggs, A., Huang, Y., Melamed, A., Szamreta, E., Monberg, M., & Wright, J. (2022). EP054/#637 Patterns of use of primary chemotherapy and first-line chemotherapy for recurrence among patients with cervical cancer. E-Posters. https://doi.org/10.1136/ijgc-2022-igcs.145

Matsuo, K., Vestal, N. L., Rau, A. R., Sangara, R. N., Youssefzadeh, A. C., Bainvoll, L., Matsuzaki, S., Roman, L. D., Ouzounian, J. G., & Wright, J. D. (2022). Gynecologic oncologists in surgery for placenta accreta spectrum: a survey for practice, experience, and interest. International Journal of Gynecologic Cancer, 32(11), 1433–1442. https://doi.org/10.1136/ijgc-2022-003830

Wenham, R., Ghamande, S., Makker, V., Hou, J., Duska, L., Matei, D., Bhave, M., Scott, R., Hawk, N., Song, T., & Armstrong, D. K. (2022). 2022-RA-1241-ESGO A multicentre, open-label phase 1/2 trial evaluating the safety, tolerability, and efficacy of morab-202, a folate receptor alpha-targeting antibody-drug conjugate in patients with selected tumour types. Ovarian Cancer, A312.3-A313. https://doi.org/10.1136/ijgc-2022-esgo.667

Jorgensen, K., Wu, C.-F., Meernik, C., Nitecki, R., Melamed, A., & Rauh-Hain, J. A. (2022). 2022-RA-838-ESGO All-cause and cancer-specific mortality after fertility-sparing surgery for stage I epithelial ovarian cancer. Fertility/Pregnancy, A175.2-A176. https://doi.org/10.1136/ijgc-2022-esgo.375

Jorgensen, K., Nitecki, R., Nichols, H., Fu, S., Wu, C.-F., Melamed, A., Brady, P., Gregor, M. C.-M., Clapp, M., Giordano, S., & Rauh-Hain, J. A. (2022). 2022-RA-848-ESGO Obstetric and neonatal outcomes after breast cancer: a population-based study. Fertility/Pregnancy, A176.1-A176. https://doi.org/10.1136/ijgc-2022-esgo.376

Ramirez, P. T., Rauh-Hain, J. A., Melamed, A., & Pareja, R. (2022). Surgical technique and surgeon volume: the pursuit of data-driven outcomes. International Journal of Gynecological Cancer, 32(8), 1089–1090. https://doi.org/10.1136/ijgc-2022-003682

Chin, C., & Damast, S. (2022). Radiation therapy in the definitive management of medically inoperable endometrial cancer. International Journal of Gynecological Cancer, 32(3), 323–331. https://doi.org/10.1136/ijgc-2021-002532

Matsuo, K., Klar, M., Nishio, S., Mikami, M., Roman, L. D., & Wright, J. D. (2022). Validation of the 2021 FIGO staging schema for advanced vulvar cancer. International Journal of Gynecological Cancer, 32(4), 474–479. https://doi.org/10.1136/ijgc-2021-003168

Gordhandas, S. B., Kahn, R., Sassine, D., Aviki, E. M., Baltich Nelson, B., Catchings, A., Liu, Y. L., Lakhman, Y., Abu-Rustum, N. R., Park, K. J., & Mueller, J. J. (2022). Gastric-type adenocarcinoma of the cervix in patients with Peutz-Jeghers syndrome: a systematic review of the literature with proposed screening guidelines. International Journal of Gynecological Cancer, 32(1), 79–88. https://doi.org/10.1136/ijgc-2021-002997